TandemAI

Revolutionizes drug discovery with AI integration.

📋 Overview of TandemAI

Founding Year

2021

Estimated Funding

$0000

Size

$0000

Locations

Shanghai

Primary Industry

Pharmaceuticals

📙 About TandemAI

TandemAI is a drug discovery platform that combines AI and physics-based algorithms with wet lab services. It enables drug researchers to streamline and collaborate on drug discovery processes in a single, integrated workspace. It accelerates research, providing teams with accessible, innovative solutions beyond traditional workflows and empowering scientists to make groundbreaking discoveries.

💰 Recent Investors of TandemAI

186 Ventures, Chengwei Capital, Investor

© 2025 Bot Memo. All Rights Reserved.

Subscribe to Bot Memo

As as subscriber, you can explore more AI startups. You also get exclusive AI market gap reports every fortnight in your inbox.*

Continue with Google *We hate spam as much as you do.